Mortality and Pre‐Hospitalization Use of Renin‐Angiotensin System Inhibitors in Patients with Hypertension and Coronavirus Disease 2019 (COVID‐19)
Chen Chen(Tongji Hospital), Dao Wen Wang(Tongji Hospital), Enrico Ammirati(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Feng Wang(Huazhong University of Science and Technology), Francesco Moroni, Ning Zhou(Tongji Hospital), Peng Chen, Guanglin Cui(University of Oxford), Jiangang Jiang(Tongji Hospital), Javid J. Moslehi(Cardiovascular Institute of the South)
Cited by 28
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.4k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
|Journal of the American College of Cardiology|2018|1.5k
Telomere dysfunction induces metabolic and mitochondrial compromise
|Nature|2011|1.3k